SCHEMBL3860844

SCHEMBL3860844

CC(=O)C(c1ccccc1)(c1ccccc1)N1CCN(CCCN(C)C)CC1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ CHRM4 P08173 2/20 0.43
▸ CHRM5 P08912 2/20 0.43
▸ CHRM3 P20309 2/20 0.43
▸ CHRM2 P08172 1/20 0.42
▸ CHRM1 P11229 1/20 0.42
▸ OPRM1 P35372 3/20 0.41
▸ DRD3 P35462 3/20 0.41
▸ DRD2 P14416 2/20 0.41
▸ DRD4 P21917 2/20 0.41
▸ LMNA P02545 1/20 0.41
▸ HTR7 P34969 1/20 0.40
▸ SLC2A1 P11166 1/20 0.40
▸ BCL2 P10415 1/20 0.39
▸ ALDH1A1 P00352 2/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ ACHE P22303 1/20 0.39
▸ GRIN2B Q13224 1/20 0.39
▸ P2RX7 Q99572 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5023966 0.84 KCNH2 (0.49) CHRM4CHRM5CHRM3CHRM2CHRM1
SCHEMBL3862213 0.80 KMT2A (0.52) CHRM3DRD2ACHE
SCHEMBL3869725 0.78 KDM4E (0.40) CHRM4CHRM5CHRM3CHRM2CHRM1
SCHEMBL3862105 0.77 HTR7 (0.43) LMNAHTR7ALDH1A1
SCHEMBL5549131 0.71 CACNA2D1 (0.56) OPRM1DRD4LMNAHTR7ALDH1A1
SCHEMBL5026280 0.71 HRH3 (0.44) CHRM1ALDH1A1
SCHEMBL5024637 0.69 KDM1A (0.47) LMNAHTR7ALDH1A1KDM4E
SCHEMBL3862119 0.69 KCNA5 (0.53) OPRM1DRD3LMNAALDH1A1KDM4E
SCHEMBL5079974 0.69 CACNA2D1 (0.58) —
SCHEMBL5026265 0.69 KMT2A (0.59) CHRM4CHRM5CHRM3CHRM2CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1670775-A4 PIPERAZINE SUBTITUTED COMPOUNDS USED AS CALCIUM CHANNEL BLOCKERS NEUROMED PHARMACEUTICALS LTD (CA) 2009-04-22 — — EP claimed
JP-2007504174-A — — 2007-03-01 — — JP claimed
EP-1670775-A1 PIPERAZINE SUBTITUTED COMPOUNDS USED AS CALCIUM CHANNEL BLOCKERS Neuromed Pharmaceuticals, Ltd. (CA) 2006-06-21 — — EP claimed
WO-2005021523-A1 PIPERAZINE SUBSTITUTED COMPOUNDS USED AS CALCIUM CHANNEL BLOCKERS NEUROMED TECHNOLOGIES, INC. (CA) 2005-03-10 — — WO claimed
EP-1871372-A1 COMBINATION THERAPY COMPRISING AN N-TYPE CALCIUM CHANNEL BLOCKER FOR THE ALLEVIATION OF PAIN Neuromed Pharmaceuticals, Ltd. (CA) 2008-01-02 — — EP disclosed
WO-2006105670-A1 COMBINATION THERAPY COMPRISING AN N-TYPE CALCIUM CHANNEL BLOCKER FOR THE ALLEVIATION OF PAIN NEUROMED PHARMACEUTICALS LTD. (CA) 2006-10-12 — — WO disclosed
Send feedback